Paul Tudor Jones's BCAX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 27,391 shares of Bicara Therapeutics Inc. (BCAX) worth $460,991, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in BCAX, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 8,661 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Bicara Therapeutics (BCAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bicara Therapeutics (BCAX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +8,661 | Add 46.24% | 27,391 | $16.83 |
| Q3 2025 | +18,730 | New Buy | 18,730 | $15.79 |
Paul Tudor Jones's Bicara Therapeutics Investment FAQs
Paul Tudor Jones first purchased Bicara Therapeutics Inc. (BCAX) in Q3 2025, acquiring 18,730 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Bicara Therapeutics Inc. (BCAX) for 2 quarters since Q3 2025.
Paul Tudor Jones's largest addition to Bicara Therapeutics Inc. (BCAX) was in Q3 2025, adding 18,730 shares worth $295,747.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 27,391 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $460,991.
As of the Q4 2025 filing, Bicara Therapeutics Inc. (BCAX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Bicara Therapeutics Inc. (BCAX) was 27,391 shares, as reported at the end of Q4 2025.